scholarly journals Progressive Heart Failure on Long after Mitral Valve Replacement for Hypertrophic Obstructive Cardiomyopathy.

1996 ◽  
Vol 25 (5) ◽  
pp. 314-317 ◽  
Author(s):  
Sakashi Noji ◽  
Nobuo Kitamura ◽  
Akimitsu Yamaguchi ◽  
Taichi Miki ◽  
Keisuke Shuntoh ◽  
...  
2011 ◽  
Vol 142 (3) ◽  
pp. 569-574.e1 ◽  
Author(s):  
Michael A. Acker ◽  
Mariell Jessup ◽  
Steven F. Bolling ◽  
Jae Oh ◽  
Randall C. Starling ◽  
...  

2004 ◽  
Vol 33 (4) ◽  
pp. 295-298
Author(s):  
Junji Yunoki ◽  
Hitoshi Ohteki ◽  
Kozo Naito ◽  
Kazuhiro Hisajima

1998 ◽  
Vol 46 (8) ◽  
pp. 747-752
Author(s):  
Yoshihiro Koh ◽  
Tadashi Okubo ◽  
Ryouhei Hoshino ◽  
Yoshiyuki Kamigaki ◽  
Shingo Ouchi

2021 ◽  
Author(s):  
Hon Chun ◽  
Bo Mei ◽  
Guang-xian Chen ◽  
Kang-ni Feng ◽  
Meng-ya Liang ◽  
...  

Abstract Background The mitral valve shows significant involvement in hypertrophic obstructive cardiomyopathy (HOCM). The mid-term outcomes of management of HOCM by prosthetic valve replacement with septal myectomy remain unclear. This study compared the prognosis of patients with and without prosthetic valve replacement. Methods From 01/2009 until 10/2015, 24 patients with HOCM underwent septal myectomy with or without valve repair/replacement were recruited. A total of 23 patients underwent echocardiographic evaluation before and after the operation. The follow-up duration ranged from 0.4 to 7 years (median 2.5 years). The Kaplan-Meier test was used to explore the association between prosthetic valve replacement and overall/disease-free survival among HOCM patients. Results A total of 9 patients underwent septal myectomy with/without mitral valve repair (MVr), and the other 15 patients underwent septal myectomy with mitral valve replacement (MVR). Six patients treated with MVR had unfavorable outcomes, including one peri-operative and three late deaths; one patient suffered from aborted sudden death, and one patient was treated for prosthetic valve endocarditis. Prosthetic valve replacement was associated with poor disease-free survival (p = 0.025). Conclusions Septal myectomy with or without-MVr was associated with a better outcome than septal myectomy with MVR in HOCM patients. The differences in prognosis were caused by more complicated left ventricular outflow tract structures and more prosthetic valve complications among patients undergoing MVR.


PEDIATRICS ◽  
1981 ◽  
Vol 67 (2) ◽  
pp. 230-235
Author(s):  
Frank M. Galioto ◽  
Frank M. Midgley ◽  
Stephen R. Shapiro ◽  
Lowell W. Perry ◽  
James M. Ciaravella ◽  
...  

Thirteen patients, ranging in age from 10 months to 19 years (mean 7.8 years) and in weight from 6.6 to 60 kg (average 29.5 kg) underwent 14 operations for mitral valve replacement with a heterograft prosthesis between January 1, 1976 and July 1, 1979 for a variety of congenital or acquired lesions. Preoperative indications included severe refractory congestive heart failure in each patient with growth retardation, which was especially prominent in the younger patients. Operative mortality was 14% (2/14) with both deaths occurring within 48 hours of operation in patients less than 6 years of age. All surgical survivors had clinical improvement as manifested by relief of symptoms, decrease in heart size, and significant growth. Routine postoperative catheterization in five patients revealed good initial postoperative results in those studied, with one patient having a second study 20 months after operation. He was found to have had degeneration of his bovine prosthesis and had subsequent successful reoperation with a porcine prosthesis. Further long-term serial catheterizations are needed to further document the history of heterograft prosthesis in children, but they are preferred to mechanical valves became of the lack of need for long-term anticoagulants and the absence of thromboembolism complications. This series suggests that mitral valve replacement, when indicated by refractory congestive heart failure and growth retardation, can be successfully performed even in infants and small children. Surgery should not be postponed to allow for subsequent patient growth if the natural history of the disease is of progression.


2015 ◽  
Vol 21 (10) ◽  
pp. S163
Author(s):  
Keisuke Yasumura ◽  
Masami Nishino ◽  
Naotaka Okamoto ◽  
Akihiro Tanaka ◽  
Naoki Mori ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document